202 related articles for article (PubMed ID: 20160035)
1. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis.
Ooi LL; Zhou H; Kalak R; Zheng Y; Conigrave AD; Seibel MJ; Dunstan CR
Cancer Res; 2010 Mar; 70(5):1835-44. PubMed ID: 20160035
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency promotes prostate cancer growth in bone.
Zheng Y; Zhou H; Ooi LL; Snir AD; Dunstan CR; Seibel MJ
Prostate; 2011 Jun; 71(9):1012-21. PubMed ID: 21541977
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR
Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491
[TBL] [Abstract][Full Text] [Related]
4. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
Zheng Y; Zhou H; Modzelewski JR; Kalak R; Blair JM; Seibel MJ; Dunstan CR
Cancer Res; 2007 Oct; 67(19):9542-8. PubMed ID: 17909065
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer.
Zinonos I; Luo KW; Labrinidis A; Liapis V; Hay S; Panagopoulos V; Denichilo M; Ko CH; Yue GG; Lau CB; Ingman W; Ponomarev V; Atkins GJ; Findlay DM; Zannettino AC; Evdokiou A
Int J Oncol; 2014 Aug; 45(2):532-40. PubMed ID: 24865346
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
Fisher JL; Thomas-Mudge RJ; Elliott J; Hards DK; Sims NA; Slavin J; Martin TJ; Gillespie MT
Cancer Res; 2006 Apr; 66(7):3620-8. PubMed ID: 16585187
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis.
Zheng Y; Zhou H; Brennan K; Blair JM; Modzelewski JR; Seibel MJ; Dunstan CR
Bone; 2007 Feb; 40(2):471-8. PubMed ID: 17092788
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of bone resorption and growth of breast cancer in the bone microenvironment.
Buijs JT; Que I; Löwik CW; Papapoulos SE; van der Pluijm G
Bone; 2009 Feb; 44(2):380-6. PubMed ID: 19041433
[TBL] [Abstract][Full Text] [Related]
9. Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis.
Chanda D; Isayeva T; Kumar S; Siegal GP; Szafran AA; Zinn KR; Reddy VV; Ponnazhagan S
Mol Ther; 2008 May; 16(5):871-8. PubMed ID: 18388919
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
11. Chronic moderate ethanol intake differentially regulates vitamin D hydroxylases gene expression in kidneys and xenografted breast cancer cells in female mice.
García-Quiroz J; García-Becerra R; Lara-Sotelo G; Avila E; López S; Santos-Martínez N; Halhali A; Ordaz-Rosado D; Barrera D; Olmos-Ortiz A; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2017 Oct; 173():148-156. PubMed ID: 27639478
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone.
Gordon AH; O'Keefe RJ; Schwarz EM; Rosier RN; Puzas JE
Cancer Res; 2005 Apr; 65(8):3209-17. PubMed ID: 15833852
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis.
Morony S; Capparelli C; Sarosi I; Lacey DL; Dunstan CR; Kostenuik PJ
Cancer Res; 2001 Jun; 61(11):4432-6. PubMed ID: 11389072
[TBL] [Abstract][Full Text] [Related]
14. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system].
Sheng L; Wu CY; Chen XF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 May; 31(5):684-9. PubMed ID: 21812275
[TBL] [Abstract][Full Text] [Related]
16. 1,25(OH)
Lu G; Li J; Chu J; Jin S; Fu Z; Miao D; Yin Y
Biomed Pharmacother; 2017 Nov; 95():1033-1039. PubMed ID: 28922720
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D--metabolism in the human breast cancer cell line MCF-7.
Diesing D; Cordes T; Fischer D; Diedrich K; Friedrich M
Anticancer Res; 2006; 26(4A):2755-9. PubMed ID: 16886688
[TBL] [Abstract][Full Text] [Related]
18. The bone remodeling environment is a factor in breast cancer bone metastasis.
Ooi LL; Zheng Y; Stalgis-Bilinski K; Dunstan CR
Bone; 2011 Jan; 48(1):66-70. PubMed ID: 20472107
[TBL] [Abstract][Full Text] [Related]
19. Long-term vitamin D deficiency in older adult C57BL/6 mice does not affect bone structure, remodeling and mineralization.
van der Meijden K; Buskermolen J; van Essen HW; Schuurman T; Steegenga WT; Brouwer-Brolsma EM; Langenbach GEJ; van Ruijven LJ; den Heijer M; Lips P; Bravenboer N
J Steroid Biochem Mol Biol; 2016 Nov; 164():344-352. PubMed ID: 26361014
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
